Health and Care: Digital Capability Debate

Full Debate: Read Full Debate
Department: Department of Health and Social Care

Health and Care: Digital Capability

James Frith Excerpts
Monday 16th November 2026

(1 day, 7 hours ago)

Commons Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
James Frith Portrait The Parliamentary Under-Secretary of State for Health and Social Care (Mr James Frith)
- View Speech - Hansard - -

With permission, I would like to make a statement on digital capability for health and care.

This Government are determined to give patients access to technology that supports their care while improving productivity. We want to give the health and care system more choice, greater resilience and less dependence on any single supplier, as well as the ability to adapt and evolve as new technologies emerge in future, with better value for taxpayers through time. These objectives require a new approach: one that will stimulate a more diverse and innovative supplier market, including greater use of sovereign AI as well as internationally developed capabilities, building on the shift from analogue to digital set out in the 10-year health plan.

As we have just been learning, the global outage of certain Microsoft systems on Friday brought home the importance of avoiding overdependence. Our future capability should avoid being locked into any single technology. We need a new approach—one that will boost competition, demand interoperability and diversify NHS technology within a safe and modern regulatory framework. That approach has three parts: investing in strategic technologies; changing how future technology capabilities are procured; and developing open standards and our safety regime.

In the Budget, my right hon. Friend the Chancellor confirmed a further £140 million for sovereign AI. The NHS will work with sovereign AI on speeding up clinical trials, monitoring medicines safety and scaling proven AI products across the NHS, such as cancer cell detection. The Government have committed to using public procurement as a strategic lever to back British industry and ensure communities benefit from growth and good jobs. We will evolve NHS procurement processes in line with that aim. Within a fair and open competition framework, we will use our purchasing power to create routes to market for innovative companies, giving British start-ups a fair crack at NHS contracts. Rather than the NHS simply buying the technology of the future, we want it to help create the market for it.

That is where the federated data platform comes in. Fragmented information stops the NHS from providing patients with effective and emotionally intelligent care. A hospital can have beds available, but struggle to match them with patients waiting to be admitted. A clinical team can waste valuable time trying to understand where patients are on a waiting list, rather than treating them. Different parts of the NHS can hold pieces of the same operational jigsaw without being able to see the whole picture. Those are just some of the problems the FDP is helping the NHS to solve.

Technology and Government priorities have moved on since the original FDP procurement in 2023 and our procurement model needs to move with them, so today I can update the House: we will begin a new procurement process along different lines from the current contract. From January, the NHS will begin this vital work with patients, our partners and the market. Formal procurement will begin in the second half of next year and we expect the full process, from engagement to completion, to take around 18 months.

This is about the NHS building on what works, while opening the next generation of FDP to the best technologies. Interoperability, resilience and trusted common standards can and must be baked into the next generation of FDP. We will also start work, alongside the new procurement, to work with different providers on developing new capabilities and expertise starting with systems used in maternity care. Innovative providers will be invited to help address the data and digital fragmentation in this important area of care, and to test how health priorities can create routes to build UK AI capability. We will announce further details within the next few weeks.

A process this important must command public trust as well as clinical confidence. Public trust is won through clear rules, transparency, independent scrutiny and a demonstrable control over who can access people’s information, for what purpose and under whose authority. That is why the design of future FDP capabilities and contractual arrangements will be informed by frontline NHS teams, patients and the public. Just as with the single patient record, we will seek views through our public deliberations programme, working with the National Data Guardian and a dedicated patient panel. The FDP is live in 142 NHS trusts and 35 integrated care boards and supports operational services including vaccine supply chains, theatre scheduling and discharge planning. Trusts and patients are benefiting from those services, and they must remain stable while the future model is designed and procured. While future arrangements are developed, and the new procurement process is completed, the current contract will remain for two years, before coming to an end.

This decision is a bridge, not the destination. While we create the conditions for new technologies and suppliers to contribute tomorrow, we are protecting the capabilities the NHS relies on today. Throughout the period, trusts and ICBs can and should still make full use of the capabilities available on the FDP to improve their performance and productivity, including those yet to sign up or fulfil its potential for them. The contract will end in March 2029, when we intend to complete the transition to the new FDP with the additional capabilities. We will ensure the necessary controls and conditions are in place to do so without disrupting patient care.

There are many advantages to having a diverse group of suppliers, but that diversity is only an asset if technologies can work together. Interoperability is vital for information to flow; common standards make that possible consistently; cyber-security protects it; and modern regulation ensures new technologies, including clinical AI, can be deployed safely and with confidence. Rather than letting innovation further fragment the NHS—letting it benefit this or that part of the system—we want to put a floor underneath innovation.

Many colleagues, including those on Select Committees, have argued for the introduction of mandatory open data standards for the health and care system. I agree with those arguments. Today, I can confirm that this Government will introduce trusted common standards that enable information to flow consistently. At the same time, our safeguards and regulation must keep pace with rapidly developing AI, so we will continue to invest in the NHS’s cyber-security, and we have accepted each of the Medicines and Healthcare products Regulatory Agency’s 44 recommendations for AI regulation on cyber-security, interoperability, and transparency. We are now developing an implementation plan for that new regulatory approach, to be published next year.

NHS organisations are already using the FDP to run and improve services for their patients. The approach I have set out today is about better outcomes for patients, giving staff the tools that they need to care, and making best use of resources for the taxpayer. It is a new approach to NHS technology, where we have a bridge to a new system that retains public confidence while promoting UK innovation—one based on competition going forward, continuity in the meantime, and NHS control throughout. I know colleagues will support those aims and I look forward to working with them as we put our approach into practice. I commend this statement to the House.

Caroline Nokes Portrait Madam Deputy Speaker (Caroline Nokes)
- Hansard - - - Excerpts

I call the shadow Secretary of State.

Damian Hinds Portrait Damian Hinds (East Hampshire) (Con)
- View Speech - Hansard - - - Excerpts

I am grateful to the Minister for advance sight of the statement. AI and tech have huge potential in health, from drug discovery to diagnostic imaging and personalised medicine, and for more preventive care, better efficacy in treatment and more time free to be with the patient. The UK is uniquely placed because of our universities and our life sciences and tech sectors—and perhaps most of all because of the national health service and its rich data.

The Health Data Research Service has been called a once-in-a-generation chance to lead the world, and in the NHS the federated data platform that the Minister spoke about is already helping to run healthcare services more effectively for the good of patients. AI will turbocharge both. However, success in delivering those better outcomes will depend on how well the service can leverage that unique NHS data resource. Public trust and confidence are critical, as is the confidence of clinicians. We need effective principles and protocols around data security and privacy. We have the Caldicott principles, GDPR and the Data Protection Act 2018, the digital technology assessment criteria within NHS England and the NHS data security and protection standards. If there is something deficient with one of them, the right thing to do is to change it. The procurement process is the right way to evaluate one supplier against another within the principles and protocols. It should be about delivering the right spec at the right price for optimal patient care. We cannot have the selection of a supplier of an IT contract being a matter of politics or a matter of Labour MPs’ tastes or distastes.

I ask the Minister: what is actually different here? Interoperability and not being tied into a single supplier agreement are not bad principles to have in a procurement, and they can be written into a procurement specification. I think they already feature in procurement—the Minister will correct me if I am wrong—such as on the single patient record. Will he confirm that it will still be the case that any qualified supplier will be able to bid?

Could the Minister tell us what this line from his statement means: “Within a fair and open competition framework, we will use our purchasing power to create routes to market for innovative companies”? What is different between the old and the new federated data platforms? If there is a difference, how will he ensure that we do not get a drop-off in FDP participation and use if people in the system expect it to be a materially different system in two years’ time, rather than an evolution or upgrade?

On related matters of data privacy and public confidence, following the appalling cases where families who had already been through the most unimaginable pain in the Southport and Nottingham attacks found that their loved ones’ records had then been snooped on—there are many hundreds more instances of unauthorised access—what are the Minister and his colleagues doing to ensure that there are consistent penalties sufficient to act as a proper deterrent against that abuse, or, better still, mechanisms to block it happening at all? Can the Minister also tell us what is happening with the frontline productivity programme? How much of that funding has now been released, and for what?

Finally, the entire system has been plunged into disturbance and distraction by the Minister and his boss’s top-down reorganisation of the NHS, so where—[Laughter.] Before they laugh, they should talk to people in their local ICBs. Where in the new set-up will responsibility lie for the federated data platform and the single patient record? These clearly do not belong in a regional management layer structure, and instead belong firmly in the national health service at a national level.

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I thank the right hon. Gentleman for his customary selection of very strong questions. It is good to be across the Dispatch Box from him today.

I will start with the issue of trust. This is fundamental, because innovation can move only at the speed of trust. I take that incredibly seriously. We are today announcing a new procurement for the next iteration of the FDP programme, which builds on an increased appetite for additional capabilities. In my statement, I used the example of maternity services, but there will be others. It is fundamental, therefore, that in the ongoing use of the FDP, and of any new procurement process, my colleagues and I take every opportunity to remake the case for trusted systems, particularly on the issue of data. If data is accessed and misused, the full force of the law will fall down on those people, as has been the case. If the law is broken, they will face the consequences. People in the NHS and elsewhere should be in no doubt of that fact.

The benefits of the new FDP iteration will be a procurement process that welcomes international and UK capability alike—whether that is UK small and medium-sized enterprises that want a crack at NHS contracts, sovereign AI-backed capability in the UK or any international provider worth merit, they should be encouraged to take part in this.

This should stir interest in the future capability.

The point is this: the principle of the FDP and the benefits of the FDP are not what is being ignored. The merits are being remade, and the case for it is being remade. The additional appetite for new capabilities, potentially backed by UK sovereign capabilities, is what we are talking about today, as well as international counterparts.

On interoperability, I agree wholly with the right hon. Gentleman’s instincts that it must be baked in from the get-go. That framework still exists.

Allison Gardner Portrait Dr Allison Gardner (Stoke-on-Trent South) (Lab)
- View Speech - Hansard - - - Excerpts

At the outset, I declare that before I came to this place I previously worked with the NHS AI and digital regulations service, so I am a little bit chuffed about this statement, particularly the recommendation for a life cycle model after a project is deployed. I thank the Minister for that.

I want to raise the issue of Palantir. NHS England and Palantir claim that the current £330 million platform contributed to over 110,000 additional operations and a reduction in long-stay discharge delays of 12% to 15%. However, independent investigations by the likes of the Financial Times, the Health Foundation and digital rights groups found that that headline number was heavily skewed by a tiny minority of trusts. Additional freedom of information data and reports by the Guardian revealed that nearly a third of trusts performed fewer procedures after adoption and 29 trusts reported little or no actual use of the platforms. May I ask for the Minister’s assurance that any future contracts and future iteration of the platform will have independent oversight and auditing to ensure the platform’s efficiency and value for money, so that we do not see such exaggerated claims of performance again?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I assure my hon. Friend that scrutiny of performance is vital, both in the platform’s current and future form, and any overstated benefits should be subject to correction. The opportunity here is in launching a new procurement process for the next generation of the FDP that builds on what works now—from the metrics of the 137 of our trusts that are actively realising those benefits today. Away from any grandstanding or overstatement, it is those measures that I care about, as well as taking the responsible decision to commission new procurement and next-generation FDP while maintaining patient continuity of care as we do so.

Caroline Nokes Portrait Madam Deputy Speaker (Caroline Nokes)
- Hansard - - - Excerpts

I call the Liberal Democrat spokesperson.

Helen Morgan Portrait Helen Morgan (North Shropshire) (LD)
- View Speech - Hansard - - - Excerpts

We are glad that pressure from the Liberal Democrats, especially my hon. Friend the Member for Newton Abbot (Martin Wrigley) and the Chair of the Health and Social Care Committee, my hon. Friend the Member for Oxford West and Abingdon (Layla Moran), has helped bring about this statement. We have long been sounding the alarm about the dangerous Palantir contract, which has been shrouded in secrecy, and the need for digital sovereignty for the NHS.

The Liberal Democrats are clear that we need to get Palantir out of the NHS. A Trump-aligned tech giant should be nowhere near the data of millions of NHS patients and a piece of important national infrastructure. The whole Palantir story has been mired in secrecy and controversy. The Conservatives were wrong to sign this contract and showed a disregard for our sovereignty and security.

We have two primary objections: first, the lack of transparency surrounding the whole deal, including the opaque procurement process; secondly, the national security implications of offshoring our whole nation’s health data to a company with an appalling human rights record, run by an ally of Donald Trump.

Lack of trust in Palantir has led to doctors and patients voting with their feet, opting out of sharing their data and undermining the fundamental effectiveness of the FDP system. Will the Minister accept the core principles that the Liberal Democrats believe should underpin NHS digital transformation and, as reflected in the amendments we tabled to the Health Bill, consider our proposals for a risk assessment for all non-UK tech and data suppliers, an NHS digital sovereignty strategy and the prioritisation of domestic suppliers? The reality is that over the next two years this platform will become a lame duck, and we need to use that time to best effect.

James Frith Portrait Mr Frith
- View Speech - Hansard - -

The hon. Member and I agree on the opportunity given to us by a new FDP procurement process. I repeat that part of the opportunity is about fully articulating additional capabilities to realise the productivity benefits and efficiency savings that the FDP, as it exists, is already proving. The decision taken today is based on independent measures of use by 137 trusts. This is not about the politics of executives of suppliers, nor is it about the territories or customers of one company or one supplier. To repeat what I said in response to the opposition spokesperson, the right hon. Member for East Hampshire (Damian Hinds), the procurement process will be open, fair and transparent, with UK sovereign capability—SMEs in constituencies across the land—encouraged to tender, and any international capability also invited to tender.

Ben Coleman Portrait Ben Coleman (Chelsea and Fulham) (Lab)
- View Speech - Hansard - - - Excerpts

I am grateful for the thought that the Government have given to an obviously difficult situation. I am still concerned that we may be locked into Palantir. May I ask the Minister to assure us that, within a year, he will ask Palantir to prove that is not the case by moving at least one application off Foundry or another platform so we can see that we are not dependent on it anymore?

I am delighted to hear that we are moving towards a common data platform based on common standards, because, as the Minister said, that will enable the involvement of lots of British companies, creating a sovereign data offering here in the UK and helping patient care. Does the Minister therefore intend to carry on with and grow the FDP or to work on developing the common data standards—I gather Nesta is doing that at the moment, and that work could be completed in six months—and have a completely different data platform so that we can fully get rid of the albatross of Palantir hanging around the NHS’s neck once and for all?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I thank my hon. Friend not just for his engagement and questions to me today but for his counsel throughout, which has often been in corridors as we pass each other as well as formally. I look forward to further engagement with him and the Health and Social Care Committee on which he serves. We are both excited about the prospect of Government policies improving and enhancing UK sovereign capability. We recognise that the next iteration of the FDP, while including all possible suppliers and providers from the UK and internationally through an open and transparent process, brings with it new, exciting prospects for UK-based companies. I do not need to wait a year: I can confirm today that we are not locked in.

Alec Shelbrooke Portrait Sir Alec Shelbrooke (Wetherby and Easingwold) (Con)
- View Speech - Hansard - - - Excerpts

I thank the Minister for his statement. I want to probe him a little on ensuring that trust is established and maintained as other research areas, such as those from higher education, and sovereign companies may come in. Will measures be in place to stop infiltration by foreign countries buying into those companies or having research students at universities who could take data away for their own ends?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

In the common standards framework, we would expect there to be an explicit appreciation of the lineage or ownership of any particular company. The point is that the product—the FDP—is NHS-owned, as is the intellectual property and the data. Who provides the product is subject to open, robust, free procurement processes. The distinction we are making is that we recognise—not least through the appetite of those using the FDP—that the FDP can do more. I will be making the case as to why—not just now in this period of continuity of care, but in the future iteration—more trusts should sign up and take it up, and why those using it should do so fully. I look forward to using their voices to ensure that the case is made to their peers.

Josh Fenton-Glynn Portrait Josh Fenton-Glynn (Calder Valley) (Lab)
- View Speech - Hansard - - - Excerpts

I thank the Minister for his statement. I believe that something as important as NHS data should be managed by a trusted British provider, and that we should not pass up the capability to develop our own AI capability. Can he tell me what role public trust will play in the final decision? I hope he agrees that we should not give the contract to a company that the British public do not trust with their data.

James Frith Portrait Mr Frith
- View Speech - Hansard - -

My hon. Friend is absolutely right. Trust will either undermine a system or underpin it, and innovation can only move as fast as the trust therein. The opportunity today, in launching the procurement for a new iteration and next generation of the FDP, is an opportunity to remake and restate the Government’s commitment to trust in the use of data in such a system.

Martin Wrigley Portrait Martin Wrigley (Newton Abbot) (LD)
- View Speech - Hansard - - - Excerpts

I thank the Minister for his statement and for delivering quite so comprehensively what I and many colleagues across the House have been searching for for some while, particularly with the emphasis on interoperability, common standards and a new approach, which I hope will also apply to the single patient record. May I request him to specify that we stop the funding of new development on the existing Palantir system, and to investigate preventing further expansion into new trusts? May I also request him to recognise Palantir as a US supplier—rather than, as it claims, a British supplier, which it is clearly not—and to look into clarifying the actual benefits that have been delivered through the system that we have today, based on the others? And may I further congratulate him on responding to my debate tomorrow evening, before it has even taken place?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

This is the first time I have been thanked for a performance I have yet to make, so I appreciate the hon. Gentleman’s remarks.

The benefits are clear. In Greater Manchester, hospital teams book cancer tests, so patients can choose to be tested sooner at another hospital. In the midlands, we are testing regional systems and monitoring for winter performances as we head from autumn to winter. In Northampton, transfers between hospitals cut surgery waits. These are the benefits that we should be judging the system on. On the hon. Gentleman’s point about the SPR, I can confirm that interoperability will be baked in by design. The system will be secure by design and interoperable by design, in line with the new codes that he has rightly championed for so long with colleagues across the House. As to the funding, it will be at the current annual rate for the duration of the extension.

Chi Onwurah Portrait Dame Chi Onwurah (Newcastle upon Tyne Central and West) (Lab)
- View Speech - Hansard - - - Excerpts

I thank the Minister for what he has said about open data standards, but I am extremely disappointed by his decision with regard to the Palantir contract. Palantir exhibits three of the four barriers to effective digital transformation that my Committee identified in its recent report, “Rewiring the state”: hype, vendor lock-in, and a lack of digital sovereignty. If a break clause cannot be exercised because of continuity of care, it is not a break clause; it is a lock-in. In correspondence with my Committee, the Minister assured me that there were already contractual requirements that smooth continuity of care should continue. Were those assurances made in error?

I was the first person to mention Palantir in this Chamber and in Hansard, and I did so because of my concerns about how it had leveraged a £1 covid contract into a £330 million NHS contract. It has made it clear that it intends to use the next two years to embed itself even more deeply in our public services. What steps is my hon. Friend taking to ensure that other companies will have equal access, with Palantir, to the federated data platform, its existing architecture and its users? Finally, as I have mentioned to the Digital Minister, France and Germany are using open source to move away from proprietary vendors such as Palantir. What is my hon. Friend’s approach to open source in the NHS?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I thank my hon. Friend for her distinguished contribution, for the work that she leads as Chair of the Science, Innovation and Technology Committee, and for her questions, as well as for the exchange of letters that we are, ourselves, locked into. I can confirm that the contracts we are talking about include exit and transition provisions, that migration is possible in principle, and that NHS-funded IP and supplier background IP are distinct. However, given the requirement for a new iteration, given performance and the benefits already in play, and given the opportunity to add new capability, including maternity services, to a next generation of FDP, an 18 to 24-month period for commission and procurement is a reasonable assessment.

Seamus Logan Portrait Seamus Logan (Aberdeenshire North and Moray East) (SNP)
- View Speech - Hansard - - - Excerpts

The Minister has referred many times to trust and confidence, which are at the very heart of the whole problem with Palantir—or at least one of the problems. Trust and confidence are also important when it comes to the figures that the Minister quotes. He told us in his statement that 142 trusts were live on the FDP. In response to questions, he used the figure 137. That figure is very dubious: in the past few weeks, NHS England deleted that figure from its platform, because 29 trusts that were included as being live said that they were not live. I therefore make the figure 108. First, can we please be accurate about the number? Secondly, if the Minister cannot give us an assurance that the break clause will be implemented, can he confirm that Palantir’s involvement in the contract will end for good in 2029?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I can confirm that the contract will end in March 2029. I appreciate the distinction that the hon. Gentleman makes on the matter of numbers of trusts. Of the 170 trusts that are signed up, 142 are live—that effectively means they have activated it. Of the 142, 137 are realising benefits. I am happy to write to him with any follow-up data or metrics on which he seeks assurance. I repeat the point that we have the opportunity to restate and remake the case based on trust, and that we cannot expect to underpin our next generation of the FDP if we do not bring trust with us for everyone, whether they are patients or NHS workers.

Dawn Butler Portrait Dawn Butler (Brent East) (Lab)
- View Speech - Hansard - - - Excerpts

I thank the Minister for his statement. Trust is absolutely fundamental, as is the patient journey through the NHS. Although the different fragmented systems were cumbersome, they added a bit of friction, which meant that there was more security for patient data. Whoever has this contract, we need to make sure that patient data is paramount and safe. Can the Minister confirm that any data Palantir holds will be transferred wholly to a new system, and that it will have no control over any data it has had access to?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I thank my hon. Friend for her excellent question. I can confirm exactly that: the data will be transferred, and the exit and transition provisions are part of the contract. In getting my head around the issue of a federated data platform and speaking to others about it, it has helped to think of it as fetching. It fetches data, presents it to the user, and then puts it back where it was. It is, by its design as a federated model, a safer option than having one honeypot, as it were, where information and data are kept. As with the FDP as it is now, the design of any future iteration is about ensuring that that data is stored. [Interruption.] And I can see that Madam Deputy Speaker wishes for me to fetch myself and sit down!

Ayoub Khan Portrait Ayoub Khan (Birmingham Perry Barr) (Ind)
- View Speech - Hansard - - - Excerpts

I am sure the Minister will agree that this is not just about open, transparent and fair procedures in procurement; it is about trust and the ethics of the suppliers. Given Palantir’s relationship with Israel, and its destruction of Gaza’s healthcare, why should Palantir have anything to do with ours?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

We are announcing new procurement for the next generation of FDP. That is the responsible thing to do for continuity of care for patients who are benefiting from the FDP as is. That is the judgment and the announcement that we are making today. This is not, as I said earlier, about the territories in which a company has customer products, or the views of a company’s executives and their politics.

Adam Thompson Portrait Adam Thompson (Erewash) (Lab)
- View Speech - Hansard - - - Excerpts

I thank the Minister for his statement. Several constituents in Erewash have raised concerns with me regarding Palantir, covering several different matters, and the ongoing contracts. I am pleased that the Minister confirmed just a minute ago that the current contract with Palantir will end in just two years. Can he elaborate on the opportunities that will arise from that contract ending?

--- Later in debate ---
James Frith Portrait Mr Frith
- View Speech - Hansard - -

I do not want to second-guess what additional capabilities there could be. Use of the platform now is not compulsory, but it should be compelling. On the additional scope for the next generation of the FDP and the procurement, we have committed to engaging with staff, the workforce, patients, the data guardian and, of course, the House and my fellow MPs, on articulating what should come next. I look forward to those conversations.

Sorcha Eastwood Portrait Sorcha Eastwood (Lagan Valley) (Alliance)
- View Speech - Hansard - - - Excerpts

On the concerns raised by Members of this House about Palantir, the Minister has said that this is not about the views of executives or Palantir’s political views. I would challenge that; I would say, on behalf of my constituents in Lagan Valley, that the British people want to know that whenever we trust our most sensitive data to this company, we do it in a way that the vast majority of the public are happy with. I do not think they are happy with it. Would the Minister agree?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

As I have said—this is an opportunity to remake the point—we either undermine or underpin, when it comes to data systems and products in this space that the Government are providing to trusts across the country. We should not expect innovation to move faster than trust. I continue to make the case for the highest possible trust standards, and will have that conversation with patient groups, NHS staff, trusts, integrated care boards, and the range of people that we have to bring with us in this rebuild of FDP for the next generation, if we are to truly fulfil its potential.

Liz Twist Portrait Liz Twist (Blaydon and Consett) (Lab)
- View Speech - Hansard - - - Excerpts

I thank the Minister for setting out so clearly the process that will be followed as we move towards the new FDP contract. He will be aware that many people are concerned about the security of their records and how they may be used. Can he reassure patients and families that NHS organisations remain in control of their data, and that safeguards must be in place to ensure that suppliers operate only within the legal, contractual and information governance safeguards set by the NHS?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

My hon. Friend has my full assurance that that is now the case in contractual terms. I will take every opportunity to repeat our commitment to security, and to the appropriate and contractual use of data.

Jim Shannon Portrait Jim Shannon (Strangford) (DUP)
- View Speech - Hansard - - - Excerpts

I thank the Minister for his statement and answers, and I very much welcome efforts to modernise our health and care systems with digital transformation. I am asking not about which system we use, but about how it will work practically for people on the ground, including the elderly, and the rural and vulnerable patients left behind. This must never leave Northern Ireland on the sidelines. In my Strangford constituency, many older residents and those in rural areas struggle with poor broadband, or simply cannot navigate online portals to book a GP appointment or access care. Under the new system, will the Minister ensure that traditional phone and face-to-face routes are permanently protected, alongside digital tools? Will he work with the Department of Health in Northern Ireland, so that patients across all four nations can share this?

--- Later in debate ---
James Frith Portrait Mr Frith
- View Speech - Hansard - -

I can give the hon. Gentleman that commitment and my full attention to that issue. One benefit of adopting tech, and the roll-out of safely deployed AI in primary care settings, is that doctors are now able to turn and face their patients. They will not sit side-on, tapping away and administering their records; they will be giving their full attention, which will allow them to understand body language or any cues that they need to understand. One challenge we have is the fragmented system, and one answer that the FDP gives is that it brings together the fetching principle of that fragmented system, to ensure a whole view, whether that is a rural setting, a city, a coastal area, or anywhere else.

Gareth Snell Portrait Gareth Snell (Stoke-on-Trent Central) (Lab/Co-op)
- View Speech - Hansard - - - Excerpts

The Minister has my full support in trying to find a new digital system that makes the patient experience better, whether that be through the single patient record or the federated data platform. However, I worry about places like Stoke-on-Trent; Royal Stoke hospital and the University Hospitals of North Midlands NHS trust struggled just to get up to date with the electronic patient record system. How will the Government ensure that those operating on legacy systems are not left behind, and that we do not end up with a two-tier function system? Will the Minister ask his officials to take up the request from me and my hon. Friend the Member for Stafford (Leigh Ingham) for a meeting in which to discuss funding that would unlock potential savings in our trusts?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

Yes, of course I will do my bit to champion that meeting. On realising the benefits of using AI with legacy systems, or indeed a federated platform, the point is that this sits on top of legacy systems. It is provided centrally, so that the regions my hon. Friend describes do not have to commission systems for themselves; it is made available for them to benefit from. We will make sure that there is much stronger peer-to-peer advocacy for those trusts using the FDP, so that they can fully realise its benefits. My hon. Friend rightly describes a fragmented system, and the challenge is to ensure that the data is drawn together, so that a whole view can be taken, wherever someone is in the country.

Tom Hayes Portrait Tom Hayes (Bournemouth East) (Lab)
- View Speech - Hansard - - - Excerpts

As Member of Parliament for Bournemouth East, it is my democratic duty to represent the concerns of my constituents about Palantir’s involvement in our national health service. The Minister says that excellence and continuity of care is uppermost in his mind. Fast-forward the tape two years. It is clear that the Government want competition, tech sovereignty, and to back British. Britain has the skills, so will the Minister set out how, over the next two years, the Government will support British alternatives?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

The Government are ensuring, whether through the statement from my right hon. Friend the Chancellor, or through commitments made in the House, that their spending goes a long way, and that there is a first-customer principle in our economy. I look forward to that, and I appeal to businesses in my hon. Friend’s constituency, and across the country, because this should spark interest from small and medium-sized enterprises, start-ups, innovators, entrepreneurs, and established businesses that want to scale up across the country. I encourage them to apply for the next iteration of the FDP in due course.

Rachael Maskell Portrait Rachael Maskell (York Central) (Lab/Co-op)
- View Speech - Hansard - - - Excerpts

It is crucial that we establish an evidential base, not least as many of the providers listed as live have only logged on to the system once, if at all. We know that the poor capability of the current Palantir contract is slowing clinical practice, and clinicians say that it is inoperable. Will the Minister ensure that there is no further extension of the Palantir contract, and that it has no ability to ratchet and draw on further data, and will he operate the break clause in February 2027 to stop the extension and expansion of the use of Palantir?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I welcome my hon. Friend’s question. It is absolutely right that we continue to recognise the need for trust in the system to come. Correspondence from Palantir to me and the Secretary of State says that exit arrangements are clear, and that the NHS has all the rights and support that it needs to transition to a new supplier when the contract ends.

Imran Hussain Portrait Imran Hussain (Bradford East) (Lab)
- View Speech - Hansard - - - Excerpts

The Minister has announced that he is extending Palantir’s contract by two years, but he presents this as a transition to find a replacement. An extension of that length is not a transition, and why should it take another two years to find an alternative when a break clause is available? How can the Minister justify that extension, when serious concerns remain about patient data, as set out by colleagues, and given the company’s role in Israel’s genocide in Gaza? Surely the Minister should have been announcing a rejection of the extension, and that we are finally kicking Palantir out of our NHS.

James Frith Portrait Mr Frith
- View Speech - Hansard - -

The judgment that I have made begins a procurement process that will see the contract end in March 2029, and I have just given an indication of the current supplier’s acknowledgement of that fact. I am measuring the performance, and am making a judgment based on the thousands of patients who will continue to benefit from the FDP as a product in principle—not based on the supplier, or on the politics of the executives or the territories in which the company has other customers.

John McDonnell Portrait John McDonnell (Hayes and Harlington) (Lab)
- View Speech - Hansard - - - Excerpts

As my hon. Friend the Member for Bournemouth East (Tom Hayes) said, our responsibility is to represent our constituents. My constituents have made it clear that they do not want their NHS associated with a company like Palantir because of its human rights abuses, and they expect the contract to be ended. If that does not happen, and we go through this two-year period before rebidding takes place, can we ensure that we build into the criteria a good humanitarian track record? On that basis, we could then say to Palantir, “No need to apply.”

James Frith Portrait Mr Frith
- View Speech - Hansard - -

My right hon. Friend speaks to the sensitivity of some of the issues discussed today. Procurement starts today. Meetings are happening this week relating to new provider possibilities. There will be market engagement from January, to describe what the next iteration of FDP needs to include. The terms for that procurement will be issued in the coming weeks. I note my right hon. Friend’s request on what those terms should include, and thank him for it.

Alison Taylor Portrait Alison Taylor (Paisley and Renfrewshire North) (Lab)
- View Speech - Hansard - - - Excerpts

Unfortunately, as I live in Scotland, I do not have access to an NHS app, so I have to call the GP practice at 8 am and I have to call to order certain repeat prescriptions. Does the Minister agree that the SNP Government in Scotland could learn from some of the new technologies that are being adopted in England? Will he reach out to his counterpart in Scotland to discuss this with her?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I would be delighted to do that. I commit to my hon. Friend that I will reach out to my counterpart, and I am sure that there are things that I can learn from listening to the Scots. We do not intend to make the new technologies she mentions mandatory, but I hope that we can compel all areas of the United Kingdom to recognise the benefits of those systems to people, not least the Scottish people, and that the decision not to take up the NHS app—the example that she gave—is not repeated.

Emily Darlington Portrait Emily Darlington (Milton Keynes Central) (Lab)
- View Speech - Hansard - - - Excerpts

I thank the Minister and his team for engaging with me about my concerns on this issue. Data, particularly NHS data, is one of the most important things. Current US laws mean that data can be requested from any US AI company, which can then be shared. Does the Minister agree that the best way to avoid any potential transfer of copies of our data outside this country is to support British innovation and British businesses to win these contracts in the future?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I thank my hon. Friend for her championing of our UK sector. She has my full support in those efforts. As I have made clear today, I hope that this decision sparks and stirs interest in new provision and new uptake to be involved in the next iteration of the FDP model. The storing of data is a trust issue. With the current provision, just as with the next, UK storage of that data is fundamental and baked in by design.

Jack Abbott Portrait Jack Abbott (Ipswich) (Lab/Co-op)
- View Speech - Hansard - - - Excerpts

I know that people in Ipswich will want me to be direct with the Minister and say that when it comes to their data, especially their sensitive healthcare records, trust, transparency and accountability are paramount. What assurances can the Minister give in that regard, and how will those values influence future procurement decisions?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I thank my hon. Friend for his question and his typically excellent representation of his constituency. As I have said, we cannot expect to underpin trust unless we move at the speed of trust. That is about remaking the case, and giving assurances on data protection and the security by design of the system that we commission, which will be securely built. The federated nature of the platform makes the data more secure. I fully appreciate the concerns that some of his constituents have raised, and I will ensure that we continue to make the case, as we need to bring everybody with us if we are to fully realise the benefits of digital capability in our healthcare system.

Caroline Nokes Portrait Madam Deputy Speaker (Caroline Nokes)
- Hansard - - - Excerpts

No statement is complete without hearing from Harlow, so I call Chris Vince.

Chris Vince Portrait Chris Vince (Harlow) (Lab/Co-op)
- View Speech - Hansard - - - Excerpts

Harlow, as we heard previously in an ill-timed point of order, is home to some of the world’s leading tech companies, which is no real surprise considering that Harlow is the birthplace of the fibre optic cable. Will the Minister assure me that future procurement for the FDP will give British firms, like those in Harlow, a fair opportunity to compete, contribute their expertise and provide that trusted data collection that many colleagues have talked about?

James Frith Portrait Mr Frith
- View Speech - Hansard - -

I thank my hon. Friend, the heavyweight champion for Harlow, for his point, on which he has my full assurance. I hope that he will help me to communicate to the businesses in his constituency the opportunity that the new procurement process announced today will present to businesses and employers across the country.